Cetuximab in Head and Neck Cancer Patients

Conditions:   Head and Neck Cancer;   Squamous Cell Carcinoma Intervention:   Drug: Cetuximab Sponsors:   University of Wisconsin, Madison;   National Cancer Institute (NCI);   National Institute of Dental and Craniofacial Research (NIDCR) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials